Call 408.493.1800 | Fax 408.493.1801 | Toll Free 800.891.9699 (US Only) | Email: [email protected]

SDF-1alpha (CXCL12), human recombinant

based on 4 citations in multiple journalsSDF-1alpha (CXCL12), human recombinant44.1 4
A small cytokine strongly chemotactic for lymphocytes
Catalog #: 4387
SKU-Size Size Price Qty
4387-10 10 μg
$190.00
4387-50 50 μg
$525.00
4387-1000 1 mg
$2,750.00
More Sizes Get Quote

Product Details

Alternate Name SDF-1, CXCL12, Pre-B cell growth-stimulating factor, PBSF, hIRH, chemokine (C-X-C motif) ligand 12, SDF1, SDF1A, TPAR1, SCYB12, SDF-1a, TLSF-a.
Gene Symbol SDF1A
Gene ID 6387
Accession # P48061
Source E. coli
Appearance Lyophilized protein
Physical Form Description Sterile filtered and lyophilized with no additives
Molecular Weight 8.0 kDa
Purity by SDS-PAGE ≥98%
Purity by ≥98%
Endotoxin Level <0.1 ng/μg
Biological Activity Determined by its ability to chemoattract human peripheral T cells activated with PHA and IL-2 using a concentration range of 20-80 ng/ml.
Reconstitution Instructions Reconstitution in H₂O to a concentration of 0.1-1.0 mg/ml. The solution can then be diluted into other aqueous buffers or stored at 4°C for 1 week or –20°C for future use.
Handling Centrifuge the vial prior to opening.
Storage Conditions -20°C
Shipping Conditions Gel Pack
USAGE For Research Use Only! Not to be used in humans

Details

Human Stromal Cell-Derived Factor-1α (SDF-1α) is a recently discovered protein belonging to the α-chemokine (C-X-C) family of cytokines. Human SDF-1α is an 8.0 kDa protein containing 68 amino acids residues with N-terminus His-tag


Why buy BioVision Products?
Innovation
Affordability
Global Presence
Technical Support
BioVision aims to provide our customers innovative tools for accelerating drug discovery and biological research. BioVision offers >8,000 products including the most comprehensive array of assay kits for key targets in Metabolic pathways.
BioVision is committed to providing the highest quality products at a competitive price.
We have a broad network of global distributors who are ready to address your research needs and ensure fast delivery.
Our highly trained Technical Support team provides comprehensive product support and is dedicated to resolving your issues quickly and efficiently.
Tomaso,  E. et. al. Glioblastoma Recurrence after Cediranib Therapy in Patients: Lack of "Rebound" Revascularization as Mode of Escape. Cancer Res., Jan 2011; 71: 19 - 28.
Basu, S et al (2007) J. Immunol. 179: 3075-3085.
Basu, Sunanda and Broxmeyer, H. E. (2005) Blood 106: 485-493.
Miwa, S. et al. (2005) Cancer Res. 65: 8818-8825.
For more citations of this product click here